Study guide

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards

Certified Pulmonary Function Technologist CPFT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Overview & NBRC Certification Requirements

1.1 NBRC PFT Exam Logistics, Format, and Scoring Criteria 1.2 Scope of Practice, Candidate Admission Pathways, and Credential Maintenance 1.3 Professional Standards, Ethics, and Patient Safety in Diagnostic Testing

2 Chapter 2: Spirometry Equipment & Sensors

2.1 Volume-Displacement Spirometers: Water-Seal, Rolling-Seal, Bellows 2.2 Flow-Sensing Pneumotachometers: Fleisch, Lilly, Vortex, Turbine, Pitot Tube, Ultrasonic 2.3 Calibration Standards & 3-Liter Syringe Quality Control Verification

3 Chapter 3: Body Plethysmography & Hardware

3.1 Body Plethysmograph Principles: Pressure, Volume, and Variable-Pressure-Constant-Volume Design 3.2 Plethysmograph Calibration, Pressure Transducers, and Shutter Mechanics 3.3 Quality Control, Isothermal Corrections, and Leak Detection in Plethysmography

4 Chapter 4: Gas Analyzers, Environmental Sensors, & Infection Control

4.1 Rapid and Multi-Gas Analyzers: Infrared, Zirconium, Mass Spec, Electrochemical, Thermal Conductivity 4.2 Environmental Sensors, Barometric Pressure, Temperature, and BTPS Correction Factors 4.3 Infection Control, Equipment Decontamination, Disposable Filters, and Spaulding Classification 4.4 Monitors: Pulse Oximeters, Blood Pressure Devices, and ECG Equipment 4.5 Gas Delivery Systems, Valves, Absorbers, and Aerosol / Inhaler Devices

5 Chapter 5: Spirometry Protocols & ATS/ERS Criteria

5.1 Forced Vital Capacity (FVC) and Slow Vital Capacity (SVC) Testing Protocols 5.2 ATS/ERS Spirometry Acceptability, Repeatability, and Usability Criteria 5.3 Peak Expiratory Flow Rate (PEFR), Maximum Voluntary Ventilation (MVV), and Flow-Volume Loops

6 Chapter 6: Lung Volume Determination Protocols

6.1 Open-Circuit Nitrogen Washout Method: Principles, Equipment, and Calculation 6.2 Closed-Circuit Helium Dilution Method: Principles, Equipment, and Calculation 6.3 Thoracic Gas Volume (TGV/FRCpleth) and Comparison of Lung Volume Methods

7 Chapter 7: Diffusing Capacity & Bronchial Challenge Testing

7.1 Single-Breath Carbon Monoxide Diffusing Capacity (DLCO) Testing Protocol 7.2 DLCO Calculations, Hemoglobin/COHb/Altitude Corrections, and VA 7.3 Bronchial Provocation Testing: Methacholine Challenge, Exercise-Induced Bronchospasm, and EIB Protocols 7.4 Inhaled Medication Delivery Technique and Patient Education

8 Chapter 8: Cardiopulmonary Exercise & ABG Testing

8.1 Cardiopulmonary Exercise Testing (CPET) Protocols, VO2max, and Anaerobic Threshold 8.2 Six-Minute Walk Test (6MWT) Protocol, Desaturation Monitoring, and O2 Titration 8.3 Arterial Blood Gas (ABG) Sampling, Allen Test, Analyzer Maintenance, and Quality Control 8.4 Pulse Oximetry and Oxygen Assessment: Principles, Limitations, and Titration Data 8.5 CO-Oximetry / Hemoximetry: Measurement, Dyshemoglobins, and Clinical Implications 8.6 Exercise Monitoring Data: Blood Pressure Response and ECG Rhythm Analysis

9 Chapter 9: Reference Values & PFT Calculations

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards 9.2 BTPS, STPD, and ATPS Conversion Formulas and Calculations 9.3 Gas Exchange Formulas, Alveolar Air Equation, and Mechanical Calculations

10 Chapter 10: Pattern Recognition & Clinical PFT Interpretation

10.1 Obstructive Ventilatory Defects: Asthma, COPD, Emphysema, Chronic Bronchitis, Bronchiectasis 10.2 Restrictive Ventilatory Defects: Parenchymal, Chest Wall, and Neuromuscular Disorders 10.3 Mixed Ventilatory Defects, Isolated Diffusion Defects, and Reversibility Protocols

11 Chapter 11: Artifact Recognition & Quality Assurance

11.1 Spirometry Artifacts: Hesitation, Coughing, Early Termination, Glottic Closure, Leak 11.2 Lung Volume and DLCO Artifacts: Panting Frequency, Shutter Leaks, Breath-Hold Failure 11.3 Quality Control Charts, Westgard Rules, and Laboratory Quality Assurance

12 Chapter 12: Documentation, Compliance, & Emergency Safety

12.1 PFT Reporting Standards, Tabular Formats, and Interpretation Graphics 12.2 CPT Billing Codes, ICD-10 Coding, HIPAA Privacy, and EHR Compliance 12.3 Emergency Preparedness, Contraindications, and Patient Safety Management in PFT Lab

13 Chapter 13: Specialized Procedures, Home Testing & Longitudinal Data

13.1 Respiratory Muscle Strength: MIP, MEP, SNIP, and Cough Peak Flow 13.2 Sputum Sample Collection: Spontaneous and Induced Specimens 13.3 Home Testing Instruction: Home Spirometry, Peak Flow Diaries, and Home Oximetry 13.4 Pediatric Pulmonary Function Testing and Upright Versus Supine Spirometry 13.5 Serial Pulmonary Function Testing, Clinical History, Demographics, and Laboratory Quality Management

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards

Key Takeaways Explain This Topic AI

Reference equations establish predicted normative values for spirometry, lung volumes, and diffusing capacity based on key anthropometric variables: age, standing height, sex, and race or ethnicity.

The Lower Limit of Normal (LLN) is defined as the 5th percentile of a healthy, non-smoking reference population, corresponding mathematically to a Z-score of -1.645 (Mean - 1.645 x Standard Error of the Estimate).

Using a fixed 70% (0.70) FEV1/FVC ratio to define airflow obstruction causes significant overdiagnosis of obstruction in healthy elderly individuals and underdiagnosis in young adults compared to the physiologically accurate LLN.

The Global Lung Function Initiative (GLI) 2012 multi-ethnic reference equations provide continuous multi-stage predicted values across all ages (3 to 95 years), eliminating artificial transitions between pediatric and adult reference sets.

The ATS/ERS 2022 technical standards recommend race-neutral reference equations (such as GLI Global) for clinical interpretation, paired with Z-score severity grading rather than percentage of predicted cutoffs.

Last updated: August 2026

9.1 Predicted Value Equations, Reference Populations, and GLI 2012 / ATS/ERS 2022 Standards

Interpretation of pulmonary function tests (PFTs) relies entirely on comparing a patient's measured parameters against predicted normative values derived from healthy reference populations. Without accurate reference equations, clinical technologists and pulmonologists cannot determine whether a patient's lung volumes, airflow rates, or gas transfer capabilities fall within normal physiological limits or reflect pathology.

This section reviews the anthropometric determinants of lung function, the evolution of reference equations from early single-population studies to the Global Lung Function Initiative (GLI) 2012 multi-ethnic equations, the ATS/ERS 2022 updated technical standards , the mathematical definition of the Lower Limit of Normal (LLN) versus the fixed 70% ratio, and Z-score severity grading essential for the NBRC CPFT examination.

Anthropometric Determinants of Predicted Values

Predicted values for spirometry ( F V C FVC F V C , F E V 1 FEV_1 FE V 1 ​ , F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C , P E F R PEFR PEFR , F E F 25 − 75 % FEF_{25-75\%} FE F 25 − 75% ​ ), static lung volumes ( T L C TLC T L C , F R C FRC FRC , R V RV R V ), and diffusing capacity ( D L C O DLCO D L CO ) are calculated using statistical regression equations based on key anthropometric variables:

Height (Standing Height): Height is the primary structural determinant of lung volume. Taller individuals have larger thoracic cages and correspondingly larger lung capacities. Standing height must be measured accurately without shoes using a calibrated stadiometer.

Spinal Deformities and Amputations: In patients who cannot stand upright (e.g., severe kyphoscoliosis, spinal cord injury, or lower extremity amputation), arm span or sitting height must be used to estimate true standing height.

Arm Span Conversion: For adult Caucasian males, estimated height is calculated as Standing Height = Arm Span 1.06 \text{Standing Height} = \frac{\text{Arm Span}}{1.06} Standing Height = 1.06 Arm Span ​ . For adult Caucasian females, Standing Height = Arm Span 1.03 \text{Standing Height} = \frac{\text{Arm Span}}{1.03} Standing Height = 1.03 Arm Span ​ . Alternatively, a fixed ratio of 1 : 1 1:1 1 : 1 is used in specific pediatric and adult demographic models.

Age: Lung volumes increase throughout childhood and peak between ages 20 and 25. After peak maturity, lung elasticity gradually declines, causing a progressive, physiological decrease in forced expiratory volumes ( F E V 1 FEV_1 FE V 1 ​ ) and vital capacity ( F V C FVC F V C ) at an average rate of 25 to 30 mL/year in non-smoking adults.

Biological Sex: On average, males have larger lung volumes and airway diameters than females of the same height and age, due to structural differences in chest wall geometry, diaphragm mass, and lung parenchyma.

Race and Ethnicity: Historically, reference equations incorporated self-reported race/ethnicity factors, reflecting observed population-level differences in thoracic proportions (e.g., sitting-to-standing height ratios). However, contemporary standards have re-evaluated these practices.

Variable Physiological Impact Clinical / Measurement Standard

Standing Height Direct non-linear correlation with lung volume Measure without shoes; use arm span if deformed (Height = Arm Span / 1.06)

Age Declines post-peak maturity (20-25 yrs) F E V 1 FEV_1 FE V 1 ​ drops ~25-30 mL/yr in healthy adult non-smokers

Biological Sex Structural thoracic size variance Separate regression coefficients for males and females

Race / Ethnicity Historical population-based adjustment Replaced by GLI Global race-neutral standards under ATS/ERS 2022 guidelines

Evolution of Reference Equations and GLI 2012 Standards

Historically, PFT laboratories selected reference sets based on geographic proximity or local demographics. Early equations included Crapo (1981), Knudson (1983), and the NHANES III (Hankinson et al., 1999) dataset. While NHANES III established high-quality reference standards for Caucasian, African American, and Mexican American populations aged 8 to 80 years in the United States, it created artificial mathematical jump discontinuities when transitioning pediatric patients into adult equations.

Global Lung Function Initiative (GLI 2012)

To overcome these limitations, the European Respiratory Society established the Global Lung Function Initiative (GLI) . Published in 2012, GLI 2012 provided the first continuous multi-ethnic reference equations for spirometry applicable from ages 3 to 95 years .

Sample Size: Derived from 74,187 records from healthy non-smokers in 26 countries across five continents.

Statistical Model: Uses the LMS method (Lambda-Mu-Sigma), accounting for age-related changes in median values (Mu), coefficient of variation (Sigma), and skewness (Lambda).

Ethnic Modules: Included 5 distinct categories (Caucasian, African American, North East Asian, South East Asian, and Other/Mixed).

ATS/ERS 2022 Update: Race-Neutral Reference Equations

In 2022, a joint ATS/ERS taskforce recommended transitioning to race-neutral reference equations (such as GLI Global ). The taskforce noted that race is a social construct rather than a biological determinant of lung function. Self-reported race-based equations can perpetuate health disparities by underestimating disease severity or delaying disability qualification in minority populations. The ATS/ERS 2022 standards recommend applying GLI Global multi-ethnic average equations across all patient groups paired with Z-score severity interpretation.

Lower Limit of Normal (LLN) vs. Fixed 70% Ratio

A central focus of the CPFT examination is the distinction between defining airflow obstruction using the Lower Limit of Normal (LLN) versus a fixed 70% (0.70) F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C ratio.

Defining the Lower Limit of Normal (LLN)

The Lower Limit of Normal (LLN) represents the 5th percentile of a healthy, non-smoking reference population. Statistically, in a normally distributed population, 95% of healthy individuals fall above the 5th percentile, while 5% fall below. The LLN is calculated as: LLN = Predicted Value − ( 1.645 × Standard Error of the Estimate ) \text{LLN} = \text{Predicted Value} - (1.645 \times \text{Standard Error of the Estimate}) LLN = Predicted Value − ( 1.645 × Standard Error of the Estimate ) Or using Z-scores: LLN corresponds to Z = − 1.645 \text{Or using Z-scores: } \text{LLN corresponds to } Z = -1.645 Or using Z-scores: LLN corresponds to Z = − 1.645

The Physiological Flaw of the Fixed 70% Ratio

The GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines historically defined airflow obstruction as a post-bronchodilator F E V 1 / F V C < 0.70 FEV_1/FVC < 0.70 FE V 1 ​ / F V C < 0.70 . While simple to apply, using a fixed 70% ratio introduces severe clinical misclassifications:

Overdiagnosis in the Elderly: As humans age, loss of alveolar elastic recoil naturally decreases F E V 1 FEV_1 FE V 1 ​ faster than F V C FVC F V C . Consequently, healthy elderly non-smokers (aged > 65) frequently exhibit a normal, age-related F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C ratio between 63% and 68%. Using a fixed 0.70 threshold incorrectly diagnoses up to 20% of healthy elderly adults with obstructive lung disease (false positives).

Underdiagnosis in Young Adults: Healthy young adults (aged 18 to 30) normally have an F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C ratio of 82% to 88%. The LLN for a 20-year-old may be 78%. A 20-year-old asthmatic patient with an F E V 1 / F V C FEV_1/FVC FE V 1 ​ / F V C ratio of 72% has experienced a significant physiological reduction in airflow, yet the fixed 0.70 cutoff misses the diagnosis (false negative). Patient Population Fixed 0.70 Ratio Metric Physiological LLN Metric Elderly (Age > 65) False Positives (Overdiagnosis) Correct Normal Classification Young Adults (Age 18-30) False Negatives (Underdiagnosis) Correct Obstructive Identification \begin{array}{rcc}

  • \hline
  • \text{Patient Population} & \text{Fixed 0.70 Ratio Metric} & \text{Physiological LLN Metric} \\
  • \hline
  • \text{Elderly (Age > 65)} & \text{False Positives (Overdiagnosis)} & \text{Correct Normal Classification} \\

\text{Young Adults (Age 18-30)} & \text{False Negatives (Underdiagnosis)} & \text{Correct Obstructive Identification} \\

\hline

\end{array} Patient Population Elderly (Age > 65) Young Adults (Age 18-30) ​ Fixed 0.70 Ratio Metric False Positives (Overdiagnosis) False Negatives (Underdiagnosis) ​ Physiological LLN Metric Correct Normal Classification Correct Obstructive Identification ​ ​

Z-Scores and ATS/ERS 2021/2022 Severity Grading

Traditional PFT interpretation classified disease severity using percentage of predicted cutoffs (e.g., 80% predicted = normal, 65-79% = mild, 50-64% = moderate, <50% = severe). However, percent predicted fails to account for variance; a 75% predicted value may be normal for an 80-year-old but severely abnormal for a 20-year-old.

Z-Score Calculation

A Z-score (standard deviation score) expresses how many standard deviations a measured value lies above or below the predicted mean: Z -score = Measured Value − Predicted Mean Residual Standard Deviation (RSD) Z\text{-score} = \frac{\text{Measured Value} - \text{Predicted Mean}}{\text{Residual Standard Deviation (RSD)}} Z -score = Residual Standard Deviation (RSD) Measured Value − Predicted Mean ​

A Z-score of 0 0 0 indicates the measured value exactly equals predicted.

A Z-score of − 1.645 -1.645 − 1.645 marks the 5th percentile ( LLN ).

Any measured parameter with a Z-score < − 1.645 < -1.645 < − 1.645 is classified as abnormally low.

Contemporary Severity Grading (ATS/ERS Standards) Z-Score Range Severity Impairment Classification ≥ − 1.645 Normal (Within Expected Range) − 1.65 to − 2.50 Mild Impairment − 2.51 to − 4.00 Moderate Impairment < − 4.00 Severe Impairment \begin{array}{cc}

  • \hline
  • \text{Z-Score Range} & \text{Severity Impairment Classification} \\
  • \hline
  • \ge -1.645 & \text{Normal (Within Expected Range)} \\
  • 1.65 \text{ to } -2.50 & \text{Mild Impairment} \\
  • 2.51 \text{ to } -4.00 & \text{Moderate Impairment} \\
  • < -4.00 & \text{Severe Impairment} \\
  • \hline

\end{array} Z-Score Range ≥ − 1.645 − 1.65 to − 2.50 − 2.51 to − 4.00 < − 4.00 ​ Severity Impairment Classification Normal (Within Expected Range) Mild Impairment Moderate Impairment Severe Impairment ​ ​